Grand Wealth Management’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-10,000
Closed -$580 – 74
2025
Q1
$580 Hold
10,000
– – ﹤0.01% 68
2024
Q4
$1.2K Hold
10,000
– – ﹤0.01% 66
2024
Q3
$1.37K Hold
10,000
– – ﹤0.01% 65
2024
Q2
$1.46K Hold
10,000
– – ﹤0.01% 56
2024
Q1
$1.46K Hold
10,000
– – ﹤0.01% 69
2023
Q4
$2K Hold
10,000
– – ﹤0.01% 70
2023
Q3
$1.67K Hold
10,000
– – ﹤0.01% 68
2023
Q2
$2K Hold
10,000
– – ﹤0.01% 72
2023
Q1
$2.12K Hold
10,000
– – ﹤0.01% 56
2022
Q4
$1.63K Hold
10,000
– – ﹤0.01% 57
2022
Q3
$2K Hold
10,000
– – ﹤0.01% 58
2022
Q2
$2K Hold
10,000
– – ﹤0.01% 58
2022
Q1
$3K Hold
10,000
– – ﹤0.01% 58
2021
Q4
$3K Buy
+10,000
New +$4.5K ﹤0.01% 58

Other funds holding ZOM

Grand Wealth Management's ZOM Position: Q2 2025 in Review

Grand Wealth Management sold out of Zomedica Corp. (ZOM) in Q2 2025, closing a stake of 10,000 shares — an estimated $580 sold.

Grand Wealth Management first reported a position in ZOM in Q4 2021 and held it in 14 quarters. The position peaked at $3K in Q1 2022. 10 funds tracked by Wall St. Rank hold ZOM as of Q2 2025.

  • Grand Wealth Management reported no remaining Zomedica Corp. position as of Q2 2025 after selling out during the quarter.
  • Grand Wealth Management sold 10,000 Zomedica Corp. shares in Q2 2025, an estimated $580.
  • Grand Wealth Management first reported a position in Zomedica Corp. in Q4 2021 and held it in 14 quarters.
  • Grand Wealth Management's Zomedica Corp. position peaked at $3K in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2025.

Based on Grand Wealth Management's 13F filing for Q2 2025, filed 24 Jul 2025.